CNS Pharmaceuticals Inc
NASDAQ:CNSP

Watchlist Manager
CNS Pharmaceuticals Inc Logo
CNS Pharmaceuticals Inc
NASDAQ:CNSP
Watchlist
Price: 5.2813 USD -0.35% Market Closed
Market Cap: 3.3m USD

Relative Value

CNSP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of CNSP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CNSP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.3
Industry
21.4
Forward
-0.2
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.3
Industry
16.4
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.3
Industry
22.8
vs History
57
vs Industry
27
Median 3Y
0.1
Median 5Y
0.5
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
12
vs Industry
56
Median 3Y
0.2
Median 5Y
0
Industry
13
vs History
12
vs Industry
53
Median 3Y
0.2
Median 5Y
0
Industry
16.5
Forward
0.5
vs History
17
vs Industry
57
Median 3Y
0.3
Median 5Y
0
Industry
15.6
vs History
17
vs Industry
44
Median 3Y
0.3
Median 5Y
0
Industry
18.7
vs History
vs Industry
61
Median 3Y
0.3
Median 5Y
9.8
Industry
1.9

Multiples Across Competitors

CNSP Competitors Multiples
CNS Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
CNS Pharmaceuticals Inc
NASDAQ:CNSP
3m USD 0 -0.2 0.5 0.5
US
Eli Lilly and Co
NYSE:LLY
985.1B USD 16.6 53.5 35.9 38.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.6B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
259.3B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP 4.9 30.3 108.9 159.3
US
Merck & Co Inc
NYSE:MRK
267.2B USD 4.2 14 10 11.8
CH
Novartis AG
SIX:NOVN
210.7B CHF 4.8 18.5 11.7 15.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.8 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.1B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
CNS Pharmaceuticals Inc
NASDAQ:CNSP
Average P/E: 24.2
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.3
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14
15%
0.9
CH
Novartis AG
SIX:NOVN
18.5
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
CNS Pharmaceuticals Inc
NASDAQ:CNSP
Average EV/EBITDA: 399.8
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.9
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
108.9
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10
6%
1.7
CH
Novartis AG
SIX:NOVN
11.7
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
CNS Pharmaceuticals Inc
NASDAQ:CNSP
Average EV/EBIT: 1 712.2
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.8
8%
1.5
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5